Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1953 1
1973 1
1974 2
1975 1
1976 2
1977 1
1979 3
1980 1
1982 3
1984 1
1985 3
1987 1
1988 3
1989 2
1990 5
1991 7
1992 4
1993 2
1994 3
1996 4
1997 5
1998 2
1999 4
2000 1
2001 2
2002 4
2003 3
2004 4
2005 7
2006 7
2007 4
2008 11
2009 7
2010 13
2011 17
2012 14
2013 15
2014 9
2015 6
2016 9
2017 7
2018 9
2019 13
2020 11
2021 16
2022 17
2023 12
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

255 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Portal hypertension, noncirrhotic"
Page 1
Therapeutic pipeline in nonalcoholic steatohepatitis.
Vuppalanchi R, Noureddin M, Alkhouri N, Sanyal AJ. Vuppalanchi R, et al. Nat Rev Gastroenterol Hepatol. 2021 Jun;18(6):373-392. doi: 10.1038/s41575-020-00408-y. Epub 2021 Feb 10. Nat Rev Gastroenterol Hepatol. 2021. PMID: 33568794 Review.
In addition, emerging therapies for NASH cirrhosis would have to demonstrate either reversal of fibrosis with associated reduction in portal hypertension or at least delay the progression with eventual decrease in liver-related outcomes. ...In this Review, we summar …
In addition, emerging therapies for NASH cirrhosis would have to demonstrate either reversal of fibrosis with associated reduction in por …
Treatment of portal vein thrombosis: an updated narrative review.
Caiano LM, Riva N, Carrier M, Gatt A, Ageno W. Caiano LM, et al. Minerva Med. 2021 Dec;112(6):713-725. doi: 10.23736/S0026-4806.21.07526-1. Epub 2021 Apr 9. Minerva Med. 2021. PMID: 33832217 Review.
Portal vein thrombosis (PVT) is the most frequent among the splanchnic vein thrombosis, accounting for 90% of cases. ...Anticoagulant therapy in patients with acute symptomatic PVT should be started early after diagnosis, if no active bleeding, to obtain greater vessel rec …
Portal vein thrombosis (PVT) is the most frequent among the splanchnic vein thrombosis, accounting for 90% of cases. ...Anticoagulant …
Cystic fibrosis-related liver disease: Clinical presentations, diagnostic and monitoring approaches in the era of CFTR modulator therapies.
Dana J, Debray D, Beaufrère A, Hillaire S, Fabre M, Reinhold C, Baumert TF, Berteloot L, Vilgrain V. Dana J, et al. J Hepatol. 2022 Feb;76(2):420-434. doi: 10.1016/j.jhep.2021.09.042. Epub 2021 Oct 20. J Hepatol. 2022. PMID: 34678405 Review.
Portal hypertension develops in a minority of cases (about 10%) and may require specific management including liver transplantation for end-stage liver disease. Portal hypertension is usually the result of the progression of focal biliary fibrosis to m …
Portal hypertension develops in a minority of cases (about 10%) and may require specific management including liver transplant …
Portopulmonary hypertension.
Mukhtar NA, Fix OK. Mukhtar NA, et al. J Clin Gastroenterol. 2011 Sep;45(8):703-10. doi: 10.1097/MCG.0b013e31820656bd. J Clin Gastroenterol. 2011. PMID: 21325952 Review.
The development of pulmonary arterial hypertension in the setting of portal hypertension is known as portopulmonary hypertension. ...Although described in patients with both cirrhotic and noncirrhotic portal hypertension, portopulm …
The development of pulmonary arterial hypertension in the setting of portal hypertension is known as portopulmonary …
Gastrointestinal and Hepatic Manifestations of Chronic Granulomatous Disease.
Yang AH, Sullivan B, Zerbe CS, De Ravin SS, Blakely AM, Quezado MM, Marciano BE, Marko J, Ling A, Kleiner DE, Gallin JI, Malech HL, Holland SM, Heller T. Yang AH, et al. J Allergy Clin Immunol Pract. 2023 May;11(5):1401-1416. doi: 10.1016/j.jaip.2022.12.039. Epub 2023 Jan 13. J Allergy Clin Immunol Pract. 2023. PMID: 36646382 Review.
Gastrointestinal and hepatic manifestations are common in CGD and include structural changes, dysmotility, CGD-associated inflammatory bowel disease, liver abscesses, and noncirrhotic portal hypertension. The findings can be heterogeneous, and the management …
Gastrointestinal and hepatic manifestations are common in CGD and include structural changes, dysmotility, CGD-associated inflammatory bowel …
Diagnosis and management of ectopic varices in portal hypertension.
Tranah TH, Nayagam JS, Gregory S, Hughes S, Patch D, Tripathi D, Shawcross DL, Joshi D. Tranah TH, et al. Lancet Gastroenterol Hepatol. 2023 Nov;8(11):1046-1056. doi: 10.1016/S2468-1253(23)00209-1. Epub 2023 Sep 9. Lancet Gastroenterol Hepatol. 2023. PMID: 37683687 Review.
Ectopic variceal bleeding is a rare cause of gastrointestinal bleeding that can occur in settings of cirrhotic and non-cirrhotic portal hypertension and is characterised by its development at locations remote from the oesophagus and stomach. ...Low incidence and var …
Ectopic variceal bleeding is a rare cause of gastrointestinal bleeding that can occur in settings of cirrhotic and non-cirrhotic portal …
Noncirrhotic Portal Hypertension after Trastuzumab Emtansine in HER2-positive Breast Cancer as Determined by Deep Learning-measured Spleen Volume at CT.
Choi SJ, Lee SS, Jung KH, Lee JB, Kang HJ, Park HJ, Choi SH, Kim DW, Jang JK. Choi SJ, et al. Radiology. 2022 Dec;305(3):606-613. doi: 10.1148/radiol.220536. Epub 2022 Aug 9. Radiology. 2022. PMID: 35943338
Case reports have suggested an association between T-DM1 and portal hypertension. Purpose To evaluate the association of T-DM1 therapy with spleen volume changes and portal hypertension on CT scans and clinical findings compared with lapatinib a …
Case reports have suggested an association between T-DM1 and portal hypertension. Purpose To evaluate the association of T-DM1 …
Noncirrhotic portal hypertension in HIV infection.
Vispo E, Morello J, Rodriguez-Novoa S, Soriano V. Vispo E, et al. Curr Opin Infect Dis. 2011 Feb;24(1):12-8. doi: 10.1097/QCO.0b013e3283420f08. Curr Opin Infect Dis. 2011. PMID: 21157331 Review.
.), the cause of liver abnormalities remains unknown for a subset of patients, some of whom present with noncirrhotic portal hypertension (NCPH). RECENT FINDINGS: In 2006, the first reports of NCPH in HIV-infected patients attracted special attention. ...SUMM …
.), the cause of liver abnormalities remains unknown for a subset of patients, some of whom present with noncirrhotic portal …
Portopulmonary hypertension: short review.
Stauber RE, Olschewski H. Stauber RE, et al. Eur J Gastroenterol Hepatol. 2010 Apr;22(4):385-90. doi: 10.1097/MEG.0b013e3283337130. Eur J Gastroenterol Hepatol. 2010. PMID: 19907338 Review.
Portopulmonary hypertension (PoPH) is an underrecognized complication of portal hypertension, related to cirrhosis and noncirrhotic portal hypertension. ...In PoPH, such targeted treatment was found to be safe in small uncontrolled studie …
Portopulmonary hypertension (PoPH) is an underrecognized complication of portal hypertension, related to cirrhosis and …
Noncirrhotic portal hypertension in HIV-infected patients: a case control evaluation and review of the literature.
Cesari M, Schiavini M, Marchetti G, Caramma I, Ortu M, Franzetti F, Galli M, Antinori S, Milazzo L. Cesari M, et al. AIDS Patient Care STDS. 2010 Nov;24(11):697-703. doi: 10.1089/apc.2010.0160. Epub 2010 Oct 23. AIDS Patient Care STDS. 2010. PMID: 20969464 Review.
Idiopathic noncirrhotic portal hypertension (NCPH) is an infrequent but possibly underestimated cryptogenetic liver disease recently described in small series of HIV-infected patients. ...In conclusion, the etiology of NCHP is not still established, but in or …
Idiopathic noncirrhotic portal hypertension (NCPH) is an infrequent but possibly underestimated cryptogenetic liver dis …
255 results